L'Oreal SA
http://www.loreal.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From L'Oreal SA
L’Oréal Plans Largest Deal: $2.52Bn For Aesop
L’Oréal plans to acquire Australian luxury beauty brand Aesop from Natura & Co. in third quarter, subject to regulatory approvals, marking its biggest acquisition to date.
FTC Considers Adding ‘Organic’ and ‘Sustainable’ Guidance In Environmental Claims Update
FTC asks for comments on whether it should consider issuing guidance on “organic” and “sustainable” claims in an update to its Green Guides. Commission will collect public comments for 60 days beginning mid-January for first update to guides in 10 years.
As L’Oréal Sales Grow At Twice Beauty Market Rate, CEO Expects Inflation Won't Slow Consumers
L’Oréal reports CeraVe skin care sales up more than 40% year-to-date as it expands brand within US as well as in regions where it’s newly launched. French firm reported July-September sales rose 9.1% on a like-for-like basis.
In Second Review Of CeraVe ‘#1 Recommended’ Claim, L’Oreal’s Survey ‘Substantially More Reliable’
With new evidence providing “reasonable basis” for claim support, National Advertising Division reverses course on 2021 decision on J&J challenge of L’Oreal USA’s use of "#1 recommended by dermatologist" claims.
Company Information
- Industry
- Biotechnology
- Other Names / Subsidiaries
-
- L'Oreal manufactures cosmetics
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice